Jiangsu Lianhuan Pharmaceutical Dividends and Buybacks
Dividend criteria checks 3/6
Jiangsu Lianhuan Pharmaceutical is a dividend paying company with a current yield of 1.49% that is well covered by earnings.
Key information
1.5%
Dividend yield
0.2%
Buyback Yield
Total Shareholder Yield | 1.7% |
Future Dividend Yield | n/a |
Dividend Growth | 12.4% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | CN¥0.150 |
Payout ratio | 31% |
Recent dividend and buyback updates
No updates
Recent updates
Improved Earnings Required Before Jiangsu Lianhuan Pharmaceutical Co., Ltd. (SHSE:600513) Stock's 25% Jump Looks Justified
Nov 08Jiangsu Lianhuan Pharmaceutical's (SHSE:600513) Profits Appear To Have Quality Issues
Sep 11We Think That There Are More Issues For Jiangsu Lianhuan Pharmaceutical (SHSE:600513) Than Just Sluggish Earnings
Mar 12Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 600513's dividend payments have been volatile in the past 10 years.
Growing Dividend: 600513's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
Jiangsu Lianhuan Pharmaceutical Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (600513) | 1.5% |
Market Bottom 25% (CN) | 0.6% |
Market Top 25% (CN) | 2.2% |
Industry Average (Pharmaceuticals) | 1.7% |
Analyst forecast (600513) (up to 3 years) | n/a |
Notable Dividend: 600513's dividend (1.49%) is higher than the bottom 25% of dividend payers in the CN market (0.53%).
High Dividend: 600513's dividend (1.49%) is low compared to the top 25% of dividend payers in the CN market (2.08%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (31.3%), 600513's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its high cash payout ratio (730.3%), 600513's dividend payments are not well covered by cash flows.